资讯

证券之星11 天
Piper Sandler：重申Abbott Laboratories(ABT.US)评级
Piper Sandler：重申Abbott Laboratories(ABT.US)评级，由增持调整至增持评级, 目标价由133.00美元调整至145.00美元。 雅培（ABT.US）公司简介：雅培公司致力于 ...
ETF Daily News9 天
Piper Sandler Reiterates “Overweight” Rating for Abbott Laboratories (NYSE:ABT)
Shares of NYSE:ABT opened at $131.00 on Thursday. The business has a fifty day moving average of $130.62 and a two-hundred day moving average of $121.89. Abbott Laboratories has a 52-week low of ...
Business Insider12 天
Abbott price target raised to $145 from $133 at Piper Sandler
Piper Sandler analyst Adam Maeder raised the firm’s price target on Abbott (ABT) to $145 from $133 and keeps an Overweight rating on the shares. The firm notes Abbott reported Q1 results that ...